Androgen receptor CAG repeat length contraction in diseased and non-diseased prostatic tissues. (Q53334487)

13 May 2018

title

Androgen receptor CAG repeat length contraction in diseased and non-diseased prostatic tissues. (English)

1 reference

13 May 2018

author

Lenore K Beitel

5

1 reference

13 May 2018

author name string

Sircar K

1

1 reference

13 May 2018

Gottlieb B

2

1 reference

13 May 2018

Alvarado C

3

1 reference

13 May 2018

Aprikian A

4

1 reference

13 May 2018

Alam-Fahmy M

6

1 reference

13 May 2018

Begin L

7

1 reference

13 May 2018

Trifiro M

8

1 reference

13 May 2018

publication date

17 April 2007

1 reference

13 May 2018

Prostate Cancer and Prostatic Diseases

published in

1 reference

13 May 2018

volume

10

1 reference

13 May 2018

issue

4

1 reference

13 May 2018

page(s)

360-368

1 reference

13 May 2018

Molecular biology of the androgen receptor

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

Integrative molecular concept modeling of prostate cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

Nuclear receptors and disease: androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

The CAG repeat within the androgen receptor gene and its relationship to prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

CAG polymorphic repeat length in androgen receptor gene combined with pretreatment serum testosterone level as prognostic factor in patients with metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

Differential protein expression in anatomical zones of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

Somatic mosaicism and cancer: a micro-genetic examination into the role of the androgen receptor gene in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

A comparison of hydraulic and laser capture microdissection methods for collection of single B cells, PCR, and sequencing of antibody VDJ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

p53 mutation profiling of multiple esophageal carcinoma using laser capture microdissection to demonstrate field carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

The androgen receptor mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

A novel method for the analysis of the androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

The androgen axis in recurrent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

In situ shortening of CAG repeat length within the androgen receptor gene in prostatic cancer and its possible precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

Somatic mutations at the trinucleotide repeats of androgen receptor gene in male hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

Androgen receptor expression in prostatic intraepithelial neoplasia and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

Androgen Receptor Gene Amplification and Protein Expression in Recurrent Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

Mechanistic relationship between androgen receptor polyglutamine tract truncation and androgen-dependent transcriptional hyperactivity in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

Somatic deletion events occur during early embryonic development and modify the extent of CAG expansion in subsequent generations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

Transcription promotes contraction of CAG repeat tracts in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

ANDROGEN RECEPTOR GENE AMPLIFICATION AT PRIMARY PROGRESSION PREDICTS RESPONSE TO COMBINED ANDROGEN BLOCKADE AS SECOND LINE THERAPY FOR ADVANCED PROSTATE CANCER

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

7 January 2021

Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

7 January 2021

CAG polymorphic repeat lengths in androgen receptor gene among Japanese prostate cancer patients: potential predictor of prognosis after endocrine therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

7 January 2021

Length and somatic mosaicism of CAG and GGN repeats in the androgen receptor gene and the risk of prostate cancer in men with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

7 January 2021

Clinically localised prostate cancer is microsatellite stable.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

7 January 2021

Somatic alterations of the androgen receptor CAG repeat in human colon cancer delineate a novel mutation pathway independent of microsatellite instability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

7 January 2021

Androgen receptor content of prostate carcinoma cells estimated by immunohistochemistry is related to prognosis of patients with stage D2 prostate carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

7 January 2021

Immunohistochemistry of the Androgen Receptor in Human Benign and Malignant Prostate Tissue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500967

7 January 2021

Identifiers

DOI

10.1038/SJ.PCAN.4500967

1 reference

13 May 2018

release_aj7zohbnwvdrzpxkxqbaqdn3lq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/aj7zohbnwvdrzpxkxqbaqdn3lq

24 November 2022

mapped directly with Wikidata item

1 reference

13 May 2018